These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 37739247)
1. Tailoring biomaterials for monitoring and evoking tertiary lymphoid structures. Li H; Lin WP; Zhang ZN; Sun ZJ Acta Biomater; 2023 Dec; 172():1-15. PubMed ID: 37739247 [TBL] [Abstract][Full Text] [Related]
2. Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma. Liu Z; Meng X; Tang X; Zou W; He Y Cancer Immunol Immunother; 2023 Jun; 72(6):1505-1521. PubMed ID: 36481914 [TBL] [Abstract][Full Text] [Related]
3. Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy. Zou X; Guan C; Gao J; Shi W; Cui Y; Zhong X Front Immunol; 2023; 14():1222719. PubMed ID: 37529035 [TBL] [Abstract][Full Text] [Related]
4. Tertiary Lymphoid Structures Are Associated with a Favorable Prognosis in High-Grade Serous Ovarian Cancer Patients. Zhang K; Xie X; Zou LH; Guo SQ Reprod Sci; 2023 Aug; 30(8):2468-2480. PubMed ID: 36759495 [TBL] [Abstract][Full Text] [Related]
5. Tertiary lymphoid structure patterns aid in identification of tumor microenvironment infiltration and selection of therapeutic agents in bladder cancer. An Y; Sun JX; Xu MY; Xu JZ; Ma SY; Liu CQ; Liu Z; Wang SG; Xia QD Front Immunol; 2022; 13():1049884. PubMed ID: 36420257 [TBL] [Abstract][Full Text] [Related]
6. Tertiary lymphoid structures and cytokines interconnections: The implication in cancer immunotherapy. Li H; Ding JY; Zhang MJ; Yu HJ; Sun ZJ Cancer Lett; 2023 Aug; 568():216293. PubMed ID: 37392991 [TBL] [Abstract][Full Text] [Related]
7. Tertiary Lymphoid Structure Raises Survival and Immunotherapy in HPV Li H; Zhu SW; Zhou JJ; Chen DR; Liu J; Wu ZZ; Wang WY; Zhang MJ; Sun ZJ J Dent Res; 2023 Jun; 102(6):678-688. PubMed ID: 36883630 [TBL] [Abstract][Full Text] [Related]
8. Tertiary lymphoid structures in the era of cancer immunotherapy. Sautès-Fridman C; Petitprez F; Calderaro J; Fridman WH Nat Rev Cancer; 2019 Jun; 19(6):307-325. PubMed ID: 31092904 [TBL] [Abstract][Full Text] [Related]
9. Boosting Checkpoint Immunotherapy with Biomaterials. Liu L; Pan Y; Zhao C; Huang P; Chen X; Rao L ACS Nano; 2023 Feb; 17(4):3225-3258. PubMed ID: 36746639 [TBL] [Abstract][Full Text] [Related]
10. Tertiary lymphoid structures as unique constructions associated with the organization, education, and function of tumor-infiltrating immunocytes. Chen J; Chen J; Wang L J Zhejiang Univ Sci B; 2022 Oct; 23(10):812-822. PubMed ID: 36226536 [TBL] [Abstract][Full Text] [Related]
11. Follicle-like tertiary lymphoid structures: A potential biomarker for prognosis and immunotherapy response in patients with laryngeal squamous cell carcinoma. Liang H; Zhang Z; Guan Z; Zheng S; Lou J; Liu W; Cai Q; Si Y Front Immunol; 2023; 14():1096220. PubMed ID: 36776859 [TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of tertiary lymphoid structures in esophageal squamous cell carcinoma. Deguchi S; Tanaka H; Suzuki S; Natsuki S; Mori T; Miki Y; Yoshii M; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M BMC Cancer; 2022 Jun; 22(1):699. PubMed ID: 35751038 [TBL] [Abstract][Full Text] [Related]
13. Tertiary lymphoid structures are critical for cancer prognosis and therapeutic response. Zhang Q; Wu S Front Immunol; 2022; 13():1063711. PubMed ID: 36713409 [TBL] [Abstract][Full Text] [Related]
14. The Presence of Tertiary Lymphoid Structures Provides New Insight Into the Clinicopathological Features and Prognosis of Patients With Breast Cancer. Wang B; Liu J; Han Y; Deng Y; Li J; Jiang Y Front Immunol; 2022; 13():868155. PubMed ID: 35664009 [TBL] [Abstract][Full Text] [Related]
15. Low-dose radiotherapy promotes the formation of tertiary lymphoid structures in lung adenocarcinoma. Wang D; Huang L; Qian D; Cao Y; Wu X; Xu P; Ming L; Tang J; Huang Z; Yin Y; Zhou L Front Immunol; 2023; 14():1334408. PubMed ID: 38259481 [TBL] [Abstract][Full Text] [Related]
16. Tertiary lymphoid structures: new immunotherapy biomarker. Yang F; Yang J; Wu M; Chen C; Chu X Front Immunol; 2024; 15():1394505. PubMed ID: 39026662 [TBL] [Abstract][Full Text] [Related]
17. Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application. Zhang Y; Xu M; Ren Y; Ba Y; Liu S; Zuo A; Xu H; Weng S; Han X; Liu Z Mol Cancer; 2024 Apr; 23(1):75. PubMed ID: 38582847 [TBL] [Abstract][Full Text] [Related]
18. Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma. Calderaro J; Petitprez F; Becht E; Laurent A; Hirsch TZ; Rousseau B; Luciani A; Amaddeo G; Derman J; Charpy C; Zucman-Rossi J; Fridman WH; Sautès-Fridman C J Hepatol; 2019 Jan; 70(1):58-65. PubMed ID: 30213589 [TBL] [Abstract][Full Text] [Related]
20. B Cells and Tertiary Lymphoid Structures: Friends or Foes in Cancer Immunotherapy? Lauss M; Donia M; Svane IM; Jönsson G Clin Cancer Res; 2022 May; 28(9):1751-1758. PubMed ID: 34965949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]